How to eliminate scabies parasites from fomites: A high-throughput ex vivo experimental study - 19/06/20

Doi : 10.1016/j.jaad.2019.11.069

Charlotte Bernigaud, MD, PhD ^a,^b,^c, Deepani D. Fernando, PhD ^a,^d, Hieng Lu, BAppSc (Hons) ^a, Sara Taylor, BAppSc (Hons) ^a, Gunter Hartel, PhD ^e, Olivier Chosidow, MD, PhD ^b, Katja Fischer, PhD ^a,^⁎
^a Cellular and Molecular Biology Department, Infectious Diseases Program, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia
^b Dermatology Department, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Henri Mondor, Université Paris-Est, Créteil, France
^c Research group Dynamyc, EA7380, Faculté de Médecine, Université Paris-Est, Ecole nationale vétérinaire d'Alfort, USC ANSES, Créteil, France
^d Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka
^e Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia

^∗Correspondence to: Katja Fischer, PhD, QIMR Berghofer Medical Research Institute, Central, Level 11, 300 Herston Rd, Herston QLD 4006, AustraliaQIMR Berghofer Medical Research InstituteCentral, Level 11, 300 Herston RdHerstonQLD 4006Australia

Graphical abstract

Le texte complet de cet article est disponible en PDF.

	Funding sources: This work was supported by the Australian National Health and Medical Research Council (project grant APP1098804). Dr Bernigaud was supported by a PhD scholarship from the French Society of Dermatology. Dr Fernando was supported by a University of Queensland International Scholarship and by a QIMR Berghofer MRI International PhD Top-up Scholarship. Dr Fischer was supported by an Australian Research Council Future Fellowship (FT130101875). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report of this study.
	Disclosure: Dr Bernigaud reports receiving research support from Bioderma Laboratoire Dermatologique and Codexial Dermatologie. Dr Chosidow reports receiving drugs donated free of charge for research from Codexial Dermatologie and lecture fees from Zambon Laboratoire, Codexial Dermatologie, and MSD France. Drs Bernigaud and Chosidow act as unpaid scientific advisors for Medicines Development for Global Health. Dr Fernando, Mr Lu, MS Taylor, and Drs Hartel and Fischer have no conflicts of interest to declare.
	IRB approval status: Reviewed and approved by QIMRB and QASP AECs (QIMRB/P630, SA2015/03/504).
	Reprints not available from the authors.